A detailed history of Principia Wealth Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Principia Wealth Advisory, LLC holds 61 shares of ABBV stock, worth $12,780. This represents 0.01% of its overall portfolio holdings.

Number of Shares
61
Previous 35 74.29%
Holding current value
$12,780
Previous $6.22 Million 76.37%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 11, 2025

BUY
$169.2 - $216.66 $4,399 - $5,633
26 Added 74.29%
61 $11 Million
Q4 2024

Apr 11, 2025

BUY
$164.99 - $203.87 $5,774 - $7,135
35 New
35 $6.22 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $370B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Principia Wealth Advisory, LLC Portfolio

Follow Principia Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principia Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principia Wealth Advisory, LLC with notifications on news.